Showing results (51-60 of 3,270) with videos related to
Sort By:
Pageof 327
Journal of the Peripheral Nervous System : JPNS|August 26, 2000
Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic ratsM A Cotter, N E Cameron, T C HohmanDiabetologia|November 1, 1993
Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic ratsK C Dines, M A Cotter, N E CameronInternational Journal of Impotence Research|December 16, 2005
Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibitionM R Nangle, M A Cotter, N E CameronPflugers Archiv : European Journal of Physiology|January 15, 2004
An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS gene-deficient miceM R Nangle, M A Cotter, N E CameronDiabetologia|December 1, 1994
The potential contribution of endothelin-1 to neurovascular abnormalities in streptozotocin-diabetic ratsN E Cameron, K C Dines, M A CotterThe Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic ratsK C Dines, N E Cameron, M A CotterNaunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1993
Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprostM A Cotter, K C Dines, N E CameronThe American Journal of Physiology|July 1, 1991
Nerve blood flow in early experimental diabetes in rats: relation to conduction deficitsN E Cameron, M A Cotter, P A LowDiabetologia|April 1, 1993
Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic ratsN E Cameron, M A Cotter, E K MaxfieldEuropean Journal of Pharmacology|May 4, 2001
Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic ratsM A Cotter, D J Mirrlees, N E CameronPageof 327